(Fonseca-Camarillo et al., 2018) This suggested that IL-36 could be considered as another potential tool for the diagnosis of IBD activity, and the differences in IL-36β activity could be used to distinguish UC from active IBD. This evidence concerns the gene IL36B and inflammatory bowel disease.